NCT05191758

Brief Summary

The objective of the current study is to determine the dose at which Fermented Papaya Preparation ( FPP) is able to improve inducible respiratory burst outcomes in peripheral blood mononuclear cells (PBMC) and neutrophils of participants. Our investigators have reported that supplementation with standardized fermented papaya preparation (FPP) in mice improves dermal wound healing outcomes. Therefore, based on these observations, the investigators propose to study the dose at which FPP supplementation induces respiratory burst in blood-derived myeloid cells in healthy subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 2, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 13, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

February 15, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2022

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

August 21, 2023

Status Verified

August 1, 2023

Enrollment Period

5 months

First QC Date

December 2, 2021

Last Update Submit

August 17, 2023

Conditions

Keywords

fermented papayawound healing responses

Outcome Measures

Primary Outcomes (2)

  • Reactive Oxygen species (ROS) production of Leucocytes 6 weeks post supplementation

    The major objectives of the study is to study the mechanism of action on ROS production by leucocytes of healthy subjects post 6 weeks FPP supplementation measured by flowcytometry

    6 weeks post supplementation

  • Blood leukocyte phagocytosis 6 weeks post supplementation

    Blood leukocyte phagocytosis 6 weeks post supplementation via cell biology technique

    6 weeks post supplementation

Secondary Outcomes (1)

  • Leukocyte activation and cytokine production at 6 wks post supplementation

    5 weeks

Study Arms (4)

control

NO INTERVENTION

no supplements will be taken

3 grams of supplements

EXPERIMENTAL

subjects will take 3 grams of supplements once per day

Dietary Supplement: FPP supplement

6 grams of supplements

EXPERIMENTAL

subjects will take 3 grams of supplements twice per day

Dietary Supplement: FPP supplement

9 grams of supplements

EXPERIMENTAL

subjects will take 3 grams of supplements three times per day

Dietary Supplement: FPP supplement

Interventions

FPP supplementDIETARY_SUPPLEMENT

Participants will take the supplements per randomization

Also known as: Fermented Papaya Preparation Supplement (FPP), FPP
3 grams of supplements6 grams of supplements9 grams of supplements

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 18 and above
  • Subjects must be able to follow directions and give informed consent on their own

You may not qualify if:

  • Individuals who are deemed unable to understand the procedures, risks and benefits of the study, ie. Informed consent will be excluded.
  • Females who are pregnant will also be excluded to minimize the risk to such individuals (and fetus).
  • Individuals who are therapeutically immuno-compromised will also be excluded to decrease statistical variability and to minimize potential of confounders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University Health Methodist Hospital

Indianapolis, Indiana, 46228, United States

Location

Study Officials

  • Sashwati Roy, PhD

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

December 2, 2021

First Posted

January 13, 2022

Study Start

February 15, 2022

Primary Completion

July 8, 2022

Study Completion

July 31, 2023

Last Updated

August 21, 2023

Record last verified: 2023-08

Locations